Table 4.
Laboratory levels in patients and their association with the presence of fatty pancreas (FP).
| NAFLD Patients | Grade I FP | Grade II FP | p Value |
|---|---|---|---|
| N = 143 (%) | 59 (41.3%) | 84 (58.7%) | - |
| Fasting plasma glucose (mg/dL) | 105.7 ± 16 | 119.3 ± 22 | 0.052 |
| Insulin level (mmol/L) | 13.2 ± 4.9 | 15.3 ± 8.4 | 0.194 |
| Hemoglobin A1c (%) 0–6 | 62 (43.3%) | 48 (33.5%) | 0.008 * |
| >6 | 10(6.9%) | 23 (16.3%) | |
| Total cholesterol (mmol/L) | 5.72 ± 1.3 | 6.32 ± 1.2 | 0.007 * |
| HDL (mmol/L) | 1.35 ± 0.46 | 1.25 ± 0.38 | 0.153 |
| Triglycerides (mmol/L) | 1.70 ± 1.2 | 1.85 ± 1.5 | 0.20 |
| Serum amylase | 55 ± 19 | 69 ± 36 | 0.014 * |
| Serum lipase | 33 ± 13 | 40 ± 18 | 0.024 * |
| HOMA-IR score (>3) | 34 (57.6%) | 50 (58.8%) | 0.886 |
* p values highlighted with* indicate statistical significance—p value < 0.05.